Published in Surg Endosc on March 01, 2008
Standardization of D2 Lymphadenectomy and Surgical Quality Control: KLASS-02-QC | NCT01283893
Inspection of safety and accuracy of D2 lymph node dissection in laparoscopy-assisted distal gastrectomy. World J Surg (2008) 1.68
Risk of recurrence after laparoscopy-assisted radical gastrectomy for gastric cancer performed by a single surgeon. Surg Endosc (2010) 1.65
A totally laparoscopic distal gastrectomy with gastroduodenostomy (TLDG) for improvement of the early surgical outcomes in high BMI patients. Surg Endosc (2010) 1.56
Laparoscopic versus open D2 gastrectomy for advanced gastric cancer: a retrospective cohort study. Surg Endosc (2012) 1.36
Systematic review and meta-analysis of laparoscopy-assisted and open total gastrectomy for gastric cancer. World J Gastroenterol (2013) 1.24
Systematic review and meta-analysis of laparoscopic and open gastrectomy for advanced gastric cancer. World J Surg Oncol (2013) 1.15
Totally laparoscopic distal gastrectomy with D2 lymphadenectomy and Billroth II gastrojejunostomy for gastric cancer: short- and medium-term results of 139 consecutive cases from a single institution. Int J Med Sci (2013) 1.11
Comparison of long-term results between laparoscopy-assisted gastrectomy and open gastrectomy with D2 lymph node dissection for advanced gastric cancer. Surg Endosc (2011) 1.10
Video: laparoscopy distinctive technique for suprapancreatic lymph node dissection: medial approach for laparoscopic gastric cancer surgery. Surg Endosc (2011) 1.08
Various types of intracorporeal esophagojejunostomy after laparoscopic total gastrectomy for gastric cancer. Gastric Cancer (2012) 1.07
Novel integrated robotic approach for suprapancreatic D2 nodal dissection for treating gastric cancer: technique and initial experience. World J Surg (2012) 1.04
Case-matched comparison of laparoscopy-assisted and open distal gastrectomy for gastric cancer. World J Gastroenterol (2013) 1.03
Laparoscopy-assisted gastrectomy with D2 lymph node dissection for advanced gastric cancer without serosa invasion: a matched cohort study from South China. World J Surg Oncol (2013) 1.03
Standardization of D2 lymphadenectomy and surgical quality control (KLASS-02-QC): a prospective, observational, multicenter study [NCT01283893]. BMC Cancer (2014) 1.02
Comparison of Billroth I and Billroth II reconstructions after laparoscopy-assisted distal gastrectomy: a retrospective analysis of large-scale multicenter results from Korea. Surg Endosc (2010) 1.01
Laparoscopic versus open total gastrectomy for gastric cancer: an updated meta-analysis. PLoS One (2014) 0.99
Left-sided approach for suprapancreatic lymph node dissection in laparoscopy-assisted distal gastrectomy without duodenal transection. Gastric Cancer (2009) 0.98
The overlap method is a safe and feasible for esophagojejunostomy after laparoscopic-assisted total gastrectomy. World J Surg Oncol (2014) 0.96
Laparoscopic splenic hilum lymph node dissection for advanced proximal gastric cancer: a modified approach for pancreas- and spleen-preserving total gastrectomy. World J Gastroenterol (2013) 0.94
Comparison of laparoscopy-assisted and totally laparoscopic distal gastrectomy: the short-term outcome at a low volume center. J Gastric Cancer (2013) 0.89
Comparative study of laparoscopic vs open gastrectomy in gastric cancer management. World J Gastroenterol (2011) 0.89
Intracorporeal Anastomosis Using Linear Stapler in Laparoscopic Distal Gastrectomy: Comparison between Gastroduodenostomy and Gastrojejunostomy. J Gastric Cancer (2011) 0.85
Laparoscopy-assisted distal gastrectomy for overweight patients in the Asian population. Surg Today (2009) 0.85
A propensity score-matched case-control comparative study of laparoscopic and open extended (D2) lymph node dissection for distal gastric carcinoma. Surg Endosc (2013) 0.84
Laparoscopic distal gastrectomy with D2 dissection for advanced gastric cancer. Chin J Cancer Res (2013) 0.84
Surgical outcomes of 2041 consecutive laparoscopic gastrectomy procedures for gastric cancer: a large-scale case control study. PLoS One (2015) 0.84
Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations. World J Gastroenterol (2016) 0.80
Laparoscopic gastric tube formation with pyloromyotomy for reconstruction in patients with esophageal cancer. Ann Surg Treat Res (2015) 0.79
Oncologic value of laparoscopy-assisted distal gastrectomy for advanced gastric cancer: A systematic review and meta-analysis. J Minim Access Surg (2016) 0.77
Clinical significance of medial approach for suprapancreatic lymph node dissection during laparoscopic gastric cancer surgery. Surg Endosc (2014) 0.77
Technical pro & cons of the laparoscopic lymphadenectomy. Transl Gastroenterol Hepatol (2016) 0.75
Intracorporeal esophagojejunostomy using hemi-double-stapling technique after laparoscopic total gastrectomy in gastric cancer patients. Ann Surg Treat Res (2016) 0.75
Japanese Classification of Gastric Carcinoma - 2nd English Edition - Gastric Cancer (1998) 16.63
Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet (1995) 7.64
Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc (1994) 6.86
Gastric cancer treatment guidelines in Japan. Gastric Cancer (2002) 3.81
A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report. Surgery (2002) 3.75
Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg (2004) 2.18
New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg (1995) 1.96
Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg (1997) 1.58
Completely laparoscopic extraperigastric lymph node dissection for gastric malignancies located in the middle or lower third of the stomach. Gastric Cancer (1999) 1.28
Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma: a review of 43 cases. J Am Coll Surg (2003) 1.21
Laparoscopically assisted distal gastrectomy with standard radical lymph node dissection for gastric cancer. Surg Endosc (2005) 1.21
Laparoscopic D2 lymph node dissection for advanced gastric cancer located in the middle or lower third portion of the stomach. Gastric Cancer (2000) 1.13
Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery (1998) 1.11
Laparoscopic distal gastrectomy with regional lymph node dissection for gastric cancer. Surg Endosc (2003) 0.97
Laparoscopy-assisted D2 subtotal gastrectomy in early gastric cancer. Surg Laparosc Endosc Percutan Tech (2003) 0.97
Laparoscopic gastrectomy for cancer. Dig Dis (2005) 0.95
Reconstitution of human DNA repair excision nuclease in a highly defined system. J Biol Chem (1995) 3.90
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest (1998) 3.78
Rapid recovery of mycobacteria from clinical specimens using automated radiometric technic. Am J Clin Pathol (1984) 3.23
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc Natl Acad Sci U S A (1995) 3.18
Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.06
Use of lysis-centrifugation (isolator) and radiometric (BACTEC) blood culture systems for the detection of mycobacteremia. J Clin Microbiol (1985) 2.86
Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell (2001) 2.29
Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst (1971) 2.17
Abdominal amyloidosis: spectrum of radiological findings. Clin Radiol (2003) 2.10
Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol (1993) 2.07
Human DNA repair excision nuclease. Analysis of the roles of the subunits involved in dual incisions by using anti-XPG and anti-ERCC1 antibodies. J Biol Chem (1995) 1.93
Replication protein A confers structure-specific endonuclease activities to the XPF-ERCC1 and XPG subunits of human DNA repair excision nuclease. J Biol Chem (1996) 1.87
Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest (1983) 1.74
Postoperative chemoradiotherapy for gastric cancer. Ann Oncol (2003) 1.73
Can we predict spontaneous capsule passage after retention? A nationwide study to evaluate the incidence and clinical outcomes of capsule retention. Endoscopy (2007) 1.58
Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am J Physiol (1990) 1.58
Acidometric agar plate method for ampicillin susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1978) 1.56
Dicaffeoyl- or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors. Bioorg Med Chem (2001) 1.56
Endoscopic submucosal resection with double ligation technique for treatment of small rectal carcinoid tumors. Endoscopy (2006) 1.49
Morphological changes of the lateral meniscus in end-stage lateral compartment osteoarthritis of the knee. Osteoarthritis Cartilage (2011) 1.47
Primary pontine hemorrhage: a new CT classification. Neurology (1992) 1.46
The G-protein FlhF has a role in polar flagellar placement and general stress response induction in Pseudomonas putida. Mol Microbiol (2000) 1.46
Chromate-reducing properties of soluble flavoproteins from Pseudomonas putida and Escherichia coli. Appl Environ Microbiol (2004) 1.43
Comparison of BACTEC 13A medium and Du Pont isolator for detection of mycobacteremia. J Clin Microbiol (1988) 1.40
Dobutamine induced cardiogenic shock due to systolic anterior motion after mitral valve repair. Anaesth Intensive Care (2013) 1.38
Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view. Br J Cancer (2004) 1.36
Solitary pulmonary nodules in patients with extrapulmonary neoplasms. Radiology (2000) 1.35
CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol (2001) 1.32
Importance of testing stool specimens for Shiga toxins. J Clin Microbiol (2002) 1.30
Phosphorylated and unphosphorylated forms of human single-stranded DNA-binding protein are equally active in simian virus 40 DNA replication and in nucleotide excision repair. Proc Natl Acad Sci U S A (1995) 1.25
A rapid diagnosis of Campylobacter enteritis by direct smear examination. Am J Clin Pathol (1983) 1.24
Failure after core decompression in osteonecrosis of the femoral head. Int Orthop (2001) 1.23
Imipenem versus moxalactam in the treatment of serious infections. Antimicrob Agents Chemother (1983) 1.22
Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea. Eur J Surg Oncol (2007) 1.22
Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res (1998) 1.20
The structure of VanX reveals a novel amino-dipeptidase involved in mediating transposon-based vancomycin resistance. Mol Cell (1998) 1.19
Rich variety of defects in ZnO via an attractive interaction between O vacancies and Zn interstitials: origin of n-type doping. Phys Rev Lett (2009) 1.19
Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit. J Clin Invest (1984) 1.16
Identification of a rough strain of Escherichia coli O157:H7 that produces no detectable O157 antigen. J Clin Microbiol (1998) 1.15
Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings. Cancer Chemother Pharmacol (1989) 1.14
Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J (1989) 1.13
Doping by large-size-mismatched impurities: the microscopic origin of arsenic- or antimony-doped p-type zinc oxide. Phys Rev Lett (2004) 1.13
Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol (2008) 1.11
A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease. J Med Chem (1996) 1.09
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. Hum Gene Ther (2001) 1.09
Fat replacement of the exocrine pancreas. AJR Am J Roentgenol (1980) 1.08
Congenital cholesteatoma of mastoid origin. J Laryngol Otol (2007) 1.07
New photoprotecting groups: desyl and p-hydroxyphenacyl phosphate and carboxylate esters. Methods Enzymol (1998) 1.07
Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma. Invest New Drugs (2001) 1.06
Erysipelothrix endocarditis with cutaneous lesion. South Med J (1976) 1.06
Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease. Clin Nucl Med (1997) 1.06
Gene expression and protein levels of the stationary phase sigma factor, RpoS, in continuously-fed Pseudomonas aeruginosa biofilms. FEMS Microbiol Lett (2001) 1.06
Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. Eur J Cancer (2002) 1.05
Three-dimensional structure of the kringle sequence: structure of prothrombin fragment 1. Biochemistry (1986) 1.04
Ceftazidime therapy of serious bacterial infections. Antimicrob Agents Chemother (1983) 1.03
Dosimetry of iodine-131 ethiodol in the treatment of hepatoma. J Nucl Med (1988) 1.03
Adenocarcinoma of the colon with choriocarcinoma in its metastases. Cancer (1980) 1.02
Deep vein thrombosis: prophylaxis in acute spinal cord injured patients. Arch Phys Med Rehabil (1988) 1.02
Vascular structure of glioblastomas. Am J Roentgenol Radium Ther Nucl Med (1969) 1.02
Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. Anticancer Res (1999) 1.00
To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea. J Clin Microbiol (1996) 1.00
Unusual calcification in mixed papillary and follicular carcinoma of the thyroid gland. Radiology (1976) 1.00
A new natural reservoir of hantavirus: isolation of hantaviruses from lung tissues of bats. Arch Virol (1994) 0.99
Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm (2007) 0.98
Molecular cloning and characterization of a novel Jasmonate inducible pathogenesis-related class 10 protein gene, JIOsPR10, from rice (Oryza sativa L.) seedling leaves. Biochem Biophys Res Commun (2001) 0.98
Sensitive determination of bisphenol A in environmental water by gas chromatography with nitrogen-phosphorus detection after cyanomethylation. J Chromatogr A (2001) 0.98
Relevance of hepatoduodenal ligament lymph nodes in resectional surgery for gastric cancer. Br J Surg (2014) 0.97
Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer. Ann Oncol (2009) 0.96
Impact of tumor infiltration pattern into the surrounding tissue on prognosis of the subserosal gastric cancer (pT2b). Eur J Surg Oncol (2010) 0.96
The multiple murine 3 beta-hydroxysteroid dehydrogenase isoforms: structure, function, and tissue- and developmentally specific expression. Steroids (1997) 0.95
Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings. Antimicrob Agents Chemother (1983) 0.95
Anaerobiospirillum succiniciproducens. Two case reports. Am J Clin Pathol (1986) 0.95
Gallium scanning in sarcoidosis. Ann N Y Acad Sci (1976) 0.95
A simple method for maintaining fastidious organisms. Am J Clin Pathol (1976) 0.95
The molecular organization of the H-2K region of two t-haplotypes: implications for the evolution of genetic diversity. EMBO J (1987) 0.95
Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. FASEB J (2000) 0.95
The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation. J Pathol (2007) 0.94
Piperacillin therapy for Pseudomonas infections. South Med J (1983) 0.94
Ferrite particles: a new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration. J Lab Clin Med (1987) 0.94
Extrarenal manifestations of autosomal dominant polycystic kidney disease. Yonsei Med J (1997) 0.94
Effects of fentanyl pretreatment on the QTc interval during propofol induction. Anaesthesia (2008) 0.94
The mechanism of contraction by 2-chloroadenosine in cat detrusor muscle cells. J Urol (2000) 0.93
AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression. Gene Ther (2008) 0.93
Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. Int J Radiat Oncol Biol Phys (1987) 0.93
Chilaiditi syndrome caused by Fitz-Hugh-Curtis syndrome: multidetector CT findings. Abdom Imaging (2006) 0.93
Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin. Proteins (1988) 0.93
Limited stress response in Streptococcus pneumoniae. Microbiol Immunol (1999) 0.93
Memory impairment and cholinergic dysfunction by centrally administered Abeta and carboxyl-terminal fragment of Alzheimer's APP in mice. FASEB J (2001) 0.92
Femoral neuropathy caused by enlarged iliopsoas bursa associated with osteonecrosis of femoral head--a case report. Acta Orthop Scand (2000) 0.92
Protein kinase C delta regulates anti-apoptotic alphaB-crystallin in the retina of type 2 diabetes. Neurobiol Dis (2007) 0.92
Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells. Oncogene (2001) 0.92
Arterial thrombosis associated with nephrotic syndrome--a case report and review (adult cases in the English literature). J Korean Med Sci (1993) 0.92
Serological survey of antibody to Neospora caninum in Japanese dogs. J Vet Med Sci (1998) 0.91
Ceftazidime in patients with Pseudomonas infections. J Antimicrob Chemother (1983) 0.91
"Superscan" in an autosomal-dominant benign form of osteopetrosis. Clin Nucl Med (2001) 0.91
Biological nature of the effect of ascorbic acids on the growth of human leukemic cells. Cancer Res (1985) 0.91
Structure of Ca2+ prothrombin fragment 1 including the conformation of the Gla domain. Biochemistry (1989) 0.90
Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients. Bone Marrow Transplant (2009) 0.90
Septicemia and gastroenteritis due to Vibrio fetus. South Med J (1973) 0.90